{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:21:51Z","timestamp":1775175711102,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11239-020-02373-4","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T19:02:47Z","timestamp":1609614167000},"page":"577-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Platinoid effects on human plasmatic coagulation kinetics: a viscoelastic analysis"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8072-9883","authenticated-orcid":false,"given":"Vance G.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"key":"2373_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10534-016-9909-5","volume":"29","author":"VG Nielsen","year":"2016","unstructured":"Nielsen VG, Jacobsen WK (2016) Iron modulates the alpha chain of fibrinogen. Biometals 29:235\u2013238","journal-title":"Biometals"},{"key":"2373_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/MBC.0000000000000128","volume":"25","author":"VG Nielsen","year":"2014","unstructured":"Nielsen VG, Pretorius E (2014) Iron and carbon monoxide enhance coagulation and attenuate fibrinolysis by different mechanisms. Blood Coagul Fibrinolysis 25:695\u2013702","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2373_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/MBC.0000000000000160","volume":"25","author":"VG Nielsen","year":"2014","unstructured":"Nielsen VG, Pretorius E (2014) Iron-enhanced coagulation is attenuated by chelation: thrombelastographic and ultrastructural analysis. Blood Coagul Fibrinolysis 25:845\u2013850","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2373_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3892\/ijmm.2013.1585","volume":"33","author":"J Jankun","year":"2014","unstructured":"Jankun J, Landeta P, Pretorius E, Skrzypczak-Jankun E, Lipinski B (2014) Unusual clotting dynamics of plasma supplemented with iron(III). Int J Mol Med 33:367\u2013372","journal-title":"Int J Mol Med"},{"key":"2373_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/138945013804806541","volume":"14","author":"E Pretorius","year":"2013","unstructured":"Pretorius E, Bester J, Vermeulen N, Lipinski B (2013) Oxidation inhibits iron-induced blood coagulation. Curr Drug Targets 14:13\u201319","journal-title":"Curr Drug Targets"},{"key":"2373_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11239-018-1704-4","volume":"46","author":"VG Nielsen","year":"2018","unstructured":"Nielsen VG, Ward TD, Ford PM (2018) Effects of cupric chloride on coagulation in human plasma: role of fibrinogen. J Thromb Thrombolysis 46:359\u2013364","journal-title":"J Thromb Thrombolysis"},{"key":"2373_CR7","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1159\/000481841","volume":"43","author":"C Venter","year":"2017","unstructured":"Venter C, Oberholzer HM, Bester J, van Rooy MJ, Bester MJ (2017) Ultrastructural, confocal and viscoelastic characteristics of whole blood and plasma after exposure to cadmium and chromium alone and in combination: an ex vivo study. Cell Physiol Biochem 43:1288\u20131300","journal-title":"Cell Physiol Biochem"},{"key":"2373_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/01913123.2017.1327909","volume":"41","author":"S Arbi","year":"2017","unstructured":"Arbi S, Oberholzer HM, van Rooy MJ, Venter C, Bester MJ (2017) Effects of chronic exposure to mercury and cadmium alone and in combination on the coagulation system of Sprague-Dawley rats. Ultrastruct Pathol 41:275\u2013283","journal-title":"Ultrastruct Pathol"},{"key":"2373_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/0960327118818236","volume":"38","author":"MJ van Rensburg","year":"2019","unstructured":"van Rensburg MJ, van Rooy M, Bester MJ, Serem JC, Venter C, Oberholzer HM (2019) Oxidative and haemostatic effects of copper, manganese and mercury, alone and in combination at physiologically relevant levels: an ex vivo study. Hum Exp Toxicol 38:419\u2013433","journal-title":"Hum Exp Toxicol"},{"key":"2373_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000208856","volume":"41","author":"TP Elias","year":"1969","unstructured":"Elias TP (1969) An in vitro study of the effect of arsenic (As2O3) on blood clotting. Acta Haematol 41:239\u2013248","journal-title":"Acta Haematol"},{"key":"2373_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11239-019-01921-x","volume":"48","author":"VG Nielsen","year":"2019","unstructured":"Nielsen VG (2019) Lethal concentrations of mercury or lead do not affect coagulation kinetics in human plasma. J Thromb Thrombolysis 48:697\u2013698","journal-title":"J Thromb Thrombolysis"},{"key":"2373_CR12","doi-asserted-by":"publisher","first-page":"e0189410","DOI":"10.1371\/journal.pone.0189410","volume":"12","author":"ES Kim","year":"2017","unstructured":"Kim ES, Baran AM, Mondo EL, Rodgers TD, Nielsen GC, Dougherty DW, Pandya KJ, Rich DQ, van Wijngaarden E (2017) Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer. PLoS ONE 12:e0189410","journal-title":"PLoS ONE"},{"key":"2373_CR13","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1200\/JCO.2012.42.4358","volume":"30","author":"S Seng","year":"2012","unstructured":"Seng S, Liu Z, Chiu SK, Proverbs-Singh T, Sonpavde G, Choueiri TK, Tsao C, Yu M, Hahn NM, Oh WK, Galsky MD (2012) Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. J Clin Oncol 30:4416","journal-title":"J Clin Oncol"},{"key":"2373_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2004.08.029","volume":"102","author":"R Gorodetsky","year":"2005","unstructured":"Gorodetsky R, Peylan-Ramu N, Reshef A, Gaberman E, Levdansky L, Marx G (2005) Interactions of carboplatin with fibrin(ogen), implications for local slow release chemotherapy. J Control Release 102:235\u2013245","journal-title":"J Control Release"},{"key":"2373_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1248\/bpb.16.631","volume":"16","author":"N Ohta","year":"1993","unstructured":"Ohta N, Yotsuyanagi T (1993) Alteration of fibrinogen secondary structure by cis-diamminedichloroplatinum(II) and calcium protection. Biol Pharm Bull 16:631\u2013634","journal-title":"Biol Pharm Bull"},{"key":"2373_CR16","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3390\/molecules24101995","volume":"24","author":"E Alessio","year":"2019","unstructured":"Alessio E, Messori L (2019) NAMI-A and KP1019\/1339, two iconic ruthenium anticancer drug candidates face-to-face: a case story in medicinal inorganic chemistry. Molecules 24:1995","journal-title":"Molecules"},{"key":"2373_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/187152811794352079","volume":"10","author":"AJ Chu","year":"2011","unstructured":"Chu AJ (2011) Polycations selectively blocking tissue factor-dependent FVII activation: collective in vitro anticoagulation studies. Inflamm Allergy Drug Targets 10:13\u201318","journal-title":"Inflamm Allergy Drug Targets"},{"key":"2373_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/ijms18050916","volume":"18","author":"T Khamrang","year":"2017","unstructured":"Khamrang T, Hung KC, Hsia CH, Hsieh CY, Velusamy M, Jayakumar T, Sheu JR (2017) Antiplatelet activity of a newly synthesized novel ruthenium (II): a potential role for Akt\/JNK signaling. Int J Mol Sci 18:916","journal-title":"Int J Mol Sci"},{"key":"2373_CR19","doi-asserted-by":"publisher","first-page":"9556","DOI":"10.1038\/s41598-017-09695-z","volume":"7","author":"CH Hsia","year":"2017","unstructured":"Hsia CH, Velusamy M, Sheu JR, Khamrang T, Jayakumar T, Lu WJ, Lin KH, Chang CC (2017) A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: ex vivo and in vivo studies. Sci Rep 7:9556","journal-title":"Sci Rep"},{"key":"2373_CR20","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.3390\/ijms21082970","volume":"21","author":"VG Nielsen","year":"2020","unstructured":"Nielsen VG (2020) Ruthenium, not carbon monoxide, inhibits the procoagulant activity of atheris, echis, and pseudonaja venoms. Int J Mol Sci 21:2970","journal-title":"Int J Mol Sci"},{"key":"2373_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00280-008-0898-0","volume":"64","author":"IR Konings","year":"2009","unstructured":"Konings IR, Engels FK, Sleijfer S, Verweij J, Wiemer EA, Loos WJ (2009) Application of prolonged microdialysis sampling in carboplatin-treated cancer patients. Cancer Chemother Pharmacol 64:509-516A","journal-title":"Cancer Chemother Pharmacol"},{"key":"2373_CR22","first-page":"461","volume":"42","author":"A Clerico","year":"2006","unstructured":"Clerico A, Cappelli C, Ragni G, Caroli S, De Ioris MA, Sordi A, Petrucci F, Bocca B, Alimonti A (2006) Evaluation of carboplatin pharmacokinetics in pediatric oncology by means of inductively coupled plasma mass spectrometry. Ann Ist Super Sanit\u00e0 42:461\u2013468","journal-title":"Ann Ist Super Sanit\u00e0"},{"key":"2373_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MBC.0b013e32802f7d91","volume":"18","author":"VG Nielsen","year":"2007","unstructured":"Nielsen VG, Kirklin JK, Hoogendoorn H, Ellis TC, Holman WL (2007) Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics. Blood Coagul Fibrinolysis 18:145\u2013150","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2373_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1213\/01.ANE.0000123012.24871.62","volume":"99","author":"VG Nielsen","year":"2004","unstructured":"Nielsen VG, Gurley WQ Jr, Burch TM (2004) The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 99:120\u2013123","journal-title":"Anesth Analg"},{"issue":"Suppl 1","key":"2373_CR25","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/S0049-3848(20)30398-4","volume":"191","author":"NA Horowitz","year":"2020","unstructured":"Horowitz NA, Brenner B (2020) Thrombosis in hematological malignancies: mechanisms and implications. Thromb Res 191(Suppl 1):S58\u2013S62","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02373-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02373-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02373-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T10:58:49Z","timestamp":1618484329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02373-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2373"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02373-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"14 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This was an in vitro investigation and did not involve any living subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}